Citations (122)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Weiqi Huang, Ling Bei & Elizabeth A. Eklund. (2013) Fas-associated phosphatase 1 mediates Fas resistance in myeloid progenitor cells expressing the Bcr–abl oncogene. Leukemia & Lymphoma 54:3, pages 619-630.
Read now
Read now
Hideyuki Yanai, Hideo Negishi & Tadatsugu Taniguchi. (2012) The IRF family of transcription factors. OncoImmunology 1:8, pages 1376-1386.
Read now
Read now
Weiqi Huang, Wei Zhou, Gurveen Saberwal, Iwona Konieczna, Elizabeth Horvath, Efstratios Katsoulidis, Leonidas C. Platanias & Elizabeth A. Eklund. (2010) Interferon Consensus Sequence Binding Protein (ICSBP) Decreases β-Catenin Activity in Myeloid Cells by Repressing GAS2 Transcription. Molecular and Cellular Biology 30:19, pages 4575-4594.
Read now
Read now
Sergey V. Kozyrev & Marta E. Alarcon-Riquelme. (2007) The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity 40:8, pages 591-601.
Read now
Read now
T Kindler, RG Meyer & T Fischer. (2002) BCR-ABL as a target for novel therapeutic interventions. Expert Opinion on Therapeutic Targets 6:1, pages 85-101.
Read now
Read now
Xiaowu Zhang, Ramesh Subrahmanyam, Ray Wong, Alec W. Gross & Ruibao Ren. (2001) The NH2-Terminal Coiled-Coil Domain and Tyrosine 177 Play Important Roles in Induction of a Myeloproliferative Disease in Mice by Bcr-Abl. Molecular and Cellular Biology 21:3, pages 840-853.
Read now
Read now
Tokiko Nagamura-Inoue, Tomohiko Tamura & Keiko Ozato. (2001) Transcription Factors that Regulate Growth and Differentiation of Myeloid Cells. International Reviews of Immunology 20:1, pages 83-105.
Read now
Read now
Articles from other publishers (115)
Xiao Huang, Tingting Ma, Yongmei Zhu, Bo Jiao, Shanhe Yu, Kankan Wang, Jian-Qing Mi & Ruibao Ren. (2021) IRF4 and IRF8 expression are associated with clinical phenotype and clinico-hematological response to hydroxyurea in essential thrombocythemia. Frontiers of Medicine 16:3, pages 403-415.
Crossref
Crossref
Christian Boni & Claudio Sorio. (2021) Current Views on the Interplay between Tyrosine Kinases and Phosphatases in Chronic Myeloid Leukemia. Cancers 13:10, pages 2311.
Crossref
Crossref
Franziska Liss, Miriam Frech, Ying Wang, Gavin Giel, Sabrina Fischer, Clara Simon, Lisa Marie Weber, Andrea Nist, Thorsten Stiewe, Andreas Neubauer, Andreas Burchert & Robert Liefke. (2021) IRF8 Is an AML-Specific Susceptibility Factor That Regulates Signaling Pathways and Proliferation of AML Cells. Cancers 13:4, pages 764.
Crossref
Crossref
Moshe Talpaz, Jessica Mercer & Rüdiger Hehlmann. 2021. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia
197
226
.
Soha Mcheik, Leticia Aptecar, Peter Coopman, Véronique D’Hondt & Gilles Freiss. (2020) Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer. Biomolecules 10:12, pages 1659.
Crossref
Crossref
Weiqi Huang, Bin Liu & Elizabeth A. Eklund. (2020) Investigating the role of the innate immune response in relapse or blast crisis in chronic myeloid leukemia. Leukemia 34:9, pages 2364-2374.
Crossref
Crossref
Peng Wang, Juanjuan Qian, Hongling Tian & Yong Zhao. 2019. Life Science in Space: Experiments on Board the SJ-10 Recoverable Satellite. Life Science in Space: Experiments on Board the SJ-10 Recoverable Satellite
205
233
.
Sabrina Inselmann, Ying Wang, Susanne Saussele, Lea Fritz, Christin Schütz, Magdalena Huber, Simone Liebler, Thomas Ernst, Dali Cai, Sarah Botschek, Cornelia Brendel, Raffaele A. Calogero, Dinko Pavlinic, Vladimir Benes, Edison T. Liu, Andreas Neubauer, Andreas Hochhaus & Andreas Burchert. (2018) Development, Function, and Clinical Significance of Plasmacytoid Dendritic Cells in Chronic Myeloid Leukemia. Cancer Research 78:21, pages 6223-6234.
Crossref
Crossref
Chirag A. Shah, Larisa Broglie, Liping Hu, Ling Bei, Weiqi Huang, Danielle B. Dressler & Elizabeth A. Eklund. (2018) Stat3 and CCAAT enhancer–binding protein β (C/ebpβ) activate Fanconi C gene transcription during emergency granulopoiesis. Journal of Biological Chemistry 293:11, pages 3937-3948.
Crossref
Crossref
F Zhao, Y Shi, Y Huang, Y Zhan, L Zhou, Y Li, Y Wan, H Li, H Huang, H Ruan, L Luo & L Li. (2017) Irf8 regulates the progression of myeloproliferative neoplasm-like syndrome via Mertk signaling in zebrafish. Leukemia 32:1, pages 149-158.
Crossref
Crossref
Marina Konopleva, Alfonso Quintás Cardama, Hagop Kantarjian & Jorge Cortes. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
29
47
.
Weiqi Huang, Ling Bei, Elizabeth E. Hjort & Elizabeth A. Eklund. (2017) Decreased calpain activity in chronic myeloid leukemia impairs apoptosis by increasing survivin in myeloid progenitors and xiap1 in differentiating granulocytes. Oncotarget 8:31, pages 50629-50641.
Crossref
Crossref
Cassie J. Clarke & Tessa L. Holyoake. (2017) Preclinical approaches in chronic myeloid leukemia: from cells to systems. Experimental Hematology 47, pages 13-23.
Crossref
Crossref
E. Cesaro, G. Sodaro, G. Montano, M. Grosso, A. Lupo & P. Costanzo. 2017. Chromatin Proteins and Transcription Factors as Therapeutic Targets. Chromatin Proteins and Transcription Factors as Therapeutic Targets
191
222
.
Elizabeth E. Hjort, Weiqi Huang, Liping Hu & Elizabeth A. Eklund. (2016) Bcr-abl regulates Stat5 through Shp2, the interferon consensus sequence binding protein (Icsbp/Irf8), growth arrest specific 2 (Gas2) and calpain. Oncotarget 7:47, pages 77635-77650.
Crossref
Crossref
Yanli Jin, Jingfeng Zhou, Fang Xu, Bei Jin, Lijing Cui, Yun Wang, Xin Du, Juan Li, Peng Li, Ruibao Ren & Jingxuan Pan. (2016) Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia. Journal of Clinical Investigation 126:10, pages 3961-3980.
Crossref
Crossref
Mohamed A. M. Ali. (2016) Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy. Molecular Diagnosis & Therapy 20:4, pages 315-333.
Crossref
Crossref
W Huang, C-H Luan, E E Hjort, L Bei, R Mishra, K M Sakamoto, L C Platanias & E A Eklund. (2016) The role of Fas-associated phosphatase 1 in leukemia stem cell persistence during tyrosine kinase inhibitor treatment of chronic myeloid leukemia. Leukemia 30:7, pages 1502-1509.
Crossref
Crossref
Liping Hu, Weiqi Huang, Elizabeth E. Hjort, Ling Bei, Leonidas C. Platanias & Elizabeth A. Eklund. (2016) The Interferon Consensus Sequence Binding Protein (Icsbp/Irf8) Is Required for Termination of Emergency Granulopoiesis. Journal of Biological Chemistry 291:8, pages 4107-4120.
Crossref
Crossref
Giorgia Montano, Tove Ullmark, Helena Jernmark-Nilsson, Gaetano Sodaro, Kristina Drott, Paola Costanzo, Karina Vidovic & Urban Gullberg. (2016) The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms’ tumor gene 1 (WT1) protein. Leukemia Research 40, pages 60-67.
Crossref
Crossref
Bradley Chereda & Junia V. Melo. 2016. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia
17
39
.
Moshe Talpaz, Jessica Mercer & Rüdiger Hehlmann. 2016. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia
207
230
.
J. Roos, B. Kühn, J. Fettel, I. V. Maucher, M. Ruthardt, A. Kahnt, T. Vorup-Jensen, C. Matrone, D. Steinhilber & T. J. Maier. 2016. Lipoxygenases in Inflammation. Lipoxygenases in Inflammation
131
157
.
Tomohiko Tamura, Daisuke Kurotaki & Shin-ichi Koizumi. (2015) Regulation of myelopoiesis by the transcription factor IRF8. International Journal of Hematology 101:4, pages 342-351.
Crossref
Crossref
Moshe Talpaz, Jessica Mercer & Rüdiger Hehlmann. (2015) The interferon-alpha revival in CML. Annals of Hematology 94:S2, pages 195-207.
Crossref
Crossref
Bradley Chereda & Junia V. Melo. (2015) Natural course and biology of CML. Annals of Hematology 94:S2, pages 107-121.
Crossref
Crossref
A Sharma, H Yun, N Jyotsana, A Chaturvedi, A Schwarzer, E Yung, C K Lai, F Kuchenbauer, B Argiropoulos, K Görlich, A Ganser, R K Humphries & M Heuser. (2014) Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling. Leukemia 29:1, pages 157-168.
Crossref
Crossref
Hiroaki Ikushima, Hideyuki Yanai & Tadatsugu Taniguchi. 2015. Inflammation and Immunity in Cancer. Inflammation and Immunity in Cancer
85
101
.
Jeremy D. Waight, Debarati Banik, Elizabeth A. Griffiths, Michael J. Nemeth & Scott I. Abrams. (2014) Regulation of the Interferon regulatory factor-8 (IRF-8) Tumor Suppressor Gene by the Signal Transducer and Activator of Transcription 5 (STAT5) Transcription Factor in Chronic Myeloid Leukemia. Journal of Biological Chemistry 289:22, pages 15642-15652.
Crossref
Crossref
Karen Shires, Iva Shankland, Shaheen Mowla, Samuel Njikan, Jai Jaymacker & Nicolas Novitzky. (2014) Serine and proline-rich ligands enriched via phage-display technology show preferential binding to BCR/ABL expressing cells. Hematology/Oncology and Stem Cell Therapy 7:1, pages 32-40.
Crossref
Crossref
Hemant Jaiswal, Monika Kaushik, Rachid Sougrat, Monica Gupta, Anup Dey, Rohit Verma, Keiko Ozato & Prafullakumar Tailor. (2013)
Batf3
and
Id2
Have a Synergistic Effect on
Irf8
-Directed Classical CD8α+ Dendritic Cell Development
. The Journal of Immunology 191:12, pages 5993-6001.
Crossref
Crossref
Tomoya Watanabe, Chie Hotta, Shin-ichi Koizumi, Kazuho Miyashita, Jun Nakabayashi, Daisuke Kurotaki, Go R. Sato, Michio Yamamoto, Masatoshi Nakazawa, Hiroyuki Fujita, Rika Sakai, Shin Fujisawa, Akira Nishiyama, Zenro Ikezawa, Michiko Aihara, Yoshiaki Ishigatsubo & Tomohiko Tamura. (2013) The Transcription Factor IRF8 Counteracts BCR-ABL to Rescue Dendritic Cell Development in Chronic Myelogenous Leukemia. Cancer Research 73:22, pages 6642-6653.
Crossref
Crossref
Marina Scheller, Jörg Schönheit, Karin Zimmermann, Ulf Leser, Frank Rosenbauer & Achim Leutz. (2013)
Cross talk between Wnt/β-catenin and
Irf8
in leukemia progression and drug resistance
. Journal of Experimental Medicine 210:11, pages 2239-2256.
Crossref
Crossref
Weiqi Huang, Ling Bei & Elizabeth A. Eklund. (2013) Fas-associated Phosphatase 1 (Fap1) Influences βCatenin Activity in Myeloid Progenitor Cells Expressing the Bcr-abl Oncogene. Journal of Biological Chemistry 288:18, pages 12766-12776.
Crossref
Crossref
Alfonso Quintás Cardama, Hagop Kantarjian & Jorge Cortes. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
29
44
.
Yvonne DöringOliver SoehnleinMaik DrechslerErdenechimeg ShagdarsurenSweena M. ChaudhariSvenja MeilerHelene HartwigMihail HristovRory R. KoenenThomas HieronymusMartin ZenkeChristian WeberAlma Zernecke. (2012) Hematopoietic Interferon Regulatory Factor 8-Deficiency Accelerates Atherosclerosis in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology 32:7, pages 1613-1623.
Crossref
Crossref
Cong Peng, Yaoyu Chen, Yi Shan, Haojian Zhang, Zhiru Guo, Dongguang Li & Shaoguang Li. (2012) LSK Derived LSK– Cells Have a High Apoptotic Rate Related to Survival Regulation of Hematopoietic and Leukemic Stem Cells. PLoS ONE 7:6, pages e38614.
Crossref
Crossref
Weiqi Huang, Liping Hu, Ling Bei, Elizabeth Hjort & Elizabeth A. Eklund. (2012) The Leukemia-associated Fusion Protein Tel-Platelet-derived Growth Factor Receptor β (Tel-PdgfRβ) Inhibits Transcriptional Repression of PTPN13 Gene by Interferon Consensus Sequence Binding Protein (Icsbp). Journal of Biological Chemistry 287:11, pages 8110-8125.
Crossref
Crossref
Seung-Hee Jo & Ruibao Ren. (2012) IRF-4 Suppresses BCR/ABL Transformation of Myeloid Cells in a DNA Binding-independent Manner. Journal of Biological Chemistry 287:3, pages 1770-1778.
Crossref
Crossref
Xiaolin Hu, Dafeng Yang, Mary Zimmerman, Feiyan Liu, Jine Yang, Swati Kannan, Andreas Burchert, Zdzislaw Szulc, Alicja Bielawska, Keiko Ozato, Kapil Bhalla & Kebin Liu. (2011) IRF8 Regulates Acid Ceramidase Expression to Mediate Apoptosis and Suppresses Myelogeneous Leukemia. Cancer Research 71:8, pages 2882-2891.
Crossref
Crossref
Seung-Hee JoJonathan H. Schatz, Jaime AcquavivaHarinder Singh & Ruibao Ren. (2010) Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis. Blood 116:15, pages 2759-2767.
Crossref
Crossref
Dhan V. Kalvakolanu, Shreeram C. Nallar & Sudhakar Kalakonda. (2010) Cytokine-induced tumor suppressors: A GRIM story. Cytokine 52:1-2, pages 128-142.
Crossref
Crossref
K Vidovic, E Svensson, B Nilsson, B Thuresson, T Olofsson, A Lennartsson & U Gullberg. (2010) Wilms’ tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells. Leukemia 24:5, pages 992-1000.
Crossref
Crossref
David Savitsky, Tomohiko Tamura, Hideyuki Yanai & Tadatsugu Taniguchi. (2010) Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunology, Immunotherapy 59:4, pages 489-510.
Crossref
Crossref
Cong Peng, Yaoyu Chen, Zhongfa Yang, Haojian Zhang, Lori Osterby, Alan G. Rosmarin & Shaoguang Li. (2010) PTEN is a tumor suppressor in CML stem cells and BCR-ABL–induced leukemias in mice. Blood 115:3, pages 626-635.
Crossref
Crossref
Gurveen Saberwal, Elizabeth Horvath, Liping Hu, Chunliu Zhu, Elizabeth Hjort & Elizabeth A. Eklund. (2009) The Interferon Consensus Sequence Binding Protein (ICSBP/IRF8) Activates Transcription of the FANCF Gene during Myeloid Differentiation. Journal of Biological Chemistry 284:48, pages 33242-33254.
Crossref
Crossref
S Kobayashi, F Kimura, T Ikeda, Y Osawa, H Torikai, A Kobayashi, K Sato & K Motoyoshi. (2009) BCR–ABL promotes neutrophil differentiation in the chronic phase of chronic myeloid leukemia by downregulating c-Jun expression. Leukemia 23:9, pages 1622-1627.
Crossref
Crossref
François Guilhot, Lydia Roy, Pierre-Jean Saulnier & Joëlle Guilhot. (2009) Interferon in chronic myeloid leukaemia: past and future. Best Practice & Research Clinical Haematology 22:3, pages 315-329.
Crossref
Crossref
Jessica KoenigsmannCornelia RudolphSandrine SanderOlivia Kershaw, Achim D. Gruber, Lars Bullinger, Brigitte SchlegelbergerDirk Carstanjen. (2009) Nf1 haploinsufficiency and Icsbp deficiency synergize in the development of leukemias. Blood 113:19, pages 4690-4701.
Crossref
Crossref
Valentina Nardi, Olaia Naveiras, Mohammad Azam & George Q. Daley. (2009) ICSBP-mediated immune protection against BCR-ABL–induced leukemia requires the CCL6 and CCL9 chemokines. Blood 113:16, pages 3813-3820.
Crossref
Crossref
Alfonso Quintás-Cardama & Jorge Cortes. (2009) Molecular biology of bcr-abl1–positive chronic myeloid leukemia. Blood 113:8, pages 1619-1630.
Crossref
Crossref
Tal Birnberg, Liat Bar-On, Anita Sapoznikov, Michele L. Caton, Luisa Cervantes-Barragán, Divine Makia, Rita Krauthgamer, Ori Brenner, Burkhard Ludewig, Damian Brockschnieder, Dieter Riethmacher, Boris Reizis & Steffen Jung. (2008) Lack of Conventional Dendritic Cells Is Compatible with Normal Development and T Cell Homeostasis, but Causes Myeloid Proliferative Syndrome. Immunity 29:6, pages 986-997.
Crossref
Crossref
Jaime Acquaviva, Xiaoren Chen & Ruibao Ren. (2008) IRF-4 functions as a tumor suppressor in early B-cell development. Blood 112:9, pages 3798-3806.
Crossref
Crossref
Paul Rosée & Michael Deininger. 2008. Chronic Myeloproliferative Disorders. Chronic Myeloproliferative Disorders
17
43
.
T Hara, M Schwieger, R Kazama, S Okamoto, K Minehata, M Ziegler, J Löhler & C Stocking. (2008) Acceleration of chronic myeloproliferation by enforced expression of Meis1 or Meis3 in Icsbp-deficient bone marrow cells. Oncogene 27:27, pages 3865-3869.
Crossref
Crossref
Tomohiko TamuraHideyuki YanaiDavid SavitskyTadatsugu Taniguchi. (2008) The IRF Family Transcription Factors in Immunity and Oncogenesis. Annual Review of Immunology 26:1, pages 535-584.
Crossref
Crossref
Akinori Takaoka, Tomohiko Tamura & Tadatsugu Taniguchi. (2008) Interferon regulatory factor family of transcription factors and regulation of oncogenesis. Cancer Science 99:3, pages 467-478.
Crossref
Crossref
Marina Tshuikina, Kenneth Nilsson & Fredrik Öberg. (2008) Positive histone marks are associated with active transcription from a methylated ICSBP/IRF8 gene. Gene 410:2, pages 259-267.
Crossref
Crossref
Richard A. Van Etten. 2008. Mouse Models of Human Blood Cancers. Mouse Models of Human Blood Cancers
1
20
.
Kristy M. Greeneltch, Monika Schneider, Seth M. Steinberg, David J. Liewehr, Trina J. Stewart, Kebin Liu & Scott I. Abrams. (2007) Host Immunosurveillance Controls Tumor Growth via IFN Regulatory Factor-8–Dependent Mechanisms. Cancer Research 67:21, pages 10406-10416.
Crossref
Crossref
Sudhakar Kalakonda, Shreeram C. Nallar, Ping Gong, Daniel J. Lindner, Simeon E. Goldblum, Sekhar P. Reddy & Dhananjaya V. Kalvakolanu. (2007) Tumor Suppressive Protein Gene Associated with Retinoid-Interferon-Induced Mortality (GRIM)-19 Inhibits src-Induced Oncogenic Transformation at Multiple Levels. The American Journal of Pathology 171:4, pages 1352-1368.
Crossref
Crossref
Richard A. Van Etten. (2007) Oncogenic signaling: new insights and controversies from chronic myeloid leukemia. Journal of Experimental Medicine 204:3, pages 461-465.
Crossref
Crossref
François Guilhot, Lydia Roy, Geraldine Martineau, Joëlle Guilhot & Frederic Millot. (2007) Immunotherapy in Chronic Myelogenous Leukemia. Clinical Lymphoma and Myeloma 7, pages S64-S70.
Crossref
Crossref
E Diaz-Blanco, I Bruns, F Neumann, J C Fischer, T Graef, M Rosskopf, B Brors, S Pechtel, S Bork, A Koch, A Baer, U-P Rohr, G Kobbe, A von Haeseler, N Gattermann, R Haas & R Kronenwett. (2007) Molecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia 21:3, pages 494-504.
Crossref
Crossref
Natalie Dror, Naama Rave-Harel, Andreas Burchert, Aviva Azriel, Tomohiko Tamura, Prafullakumar Tailor, Andreas Neubauer, Keiko Ozato & Ben-Zion Levi. (2007) Interferon Regulatory Factor-8 Is Indispensable for the Expression of Promyelocytic Leukemia and the Formation of Nuclear Bodies in Myeloid Cells. Journal of Biological Chemistry 282:8, pages 5633-5640.
Crossref
Crossref
Frank Rosenbauer & Daniel G. Tenen. (2007) Transcription factors in myeloid development: balancing differentiation with transformation. Nature Reviews Immunology 7:2, pages 105-117.
Crossref
Crossref
Junia V. Melo & John M. GoldmanDaniela Cilloni & Giuseppe Saglio. 2007. Myeloproliferative Disorders. Myeloproliferative Disorders
15
35
.
Maria Pérez-Caro & Isidro Sánchez-Garcia. 2007. Apoptosis, Cell Signaling, and Human Diseases. Apoptosis, Cell Signaling, and Human Diseases
3
34
.
Melissa Kristine Middleton, Alicia Marie Zukas, Tanya Rubinstein, Michele Jacob, Peijuan Zhu, Liang Zhao, Ian Blair & Ellen Puré. (2006) Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease. The Journal of Experimental Medicine 203:11, pages 2529-2540.
Crossref
Crossref
Kohei Kometani, Misayo Aoki, Shin Kawamata, Yoriko Shinozuka, Takumi Era, Masafumi Taniwaki, Masakazu Hattori & Nagahiro Minato. (2006) Role of SPA-1 in Phenotypes of Chronic Myelogenous Leukemia Induced by BCR-ABL–Expressing Hematopoietic Progenitors in a Mouse Model. Cancer Research 66:20, pages 9967-9976.
Crossref
Crossref
Shi Liang Ma, Annette Balle Sørensen, Sandra Kunder, Karina Dalsgaard Sørensen, Leticia Quintanilla-Martinez, David W. Morris, Jörg Schmidt & Finn Skou Pedersen. (2006) The Icsbp locus is a common proviral insertion site in mature B-cell lymphomas/plasmacytomas induced by exogenous murine leukemia virus. Virology 352:2, pages 306-318.
Crossref
Crossref
Jianguo Liu & Xiaojing Ma. (2006) Interferon Regulatory Factor 8 Regulates RANTES Gene Transcription in Cooperation with Interferon Regulatory Factor-1, NF-κB, and PU.1. Journal of Biological Chemistry 281:28, pages 19188-19195.
Crossref
Crossref
Chang Hoon Lee, Mark Melchers, Hongsheng Wang, Ted A. Torrey, Rebecca Slota, Chen-Feng Qi, Ji Young Kim, Patricia Lugar, Hee Jeong Kong, Lila Farrington, Boris van der Zouwen, Jeff X. Zhou, Vassilios Lougaris, Peter E. LipskyAmrie C. Grammer & Herbert C. MorseIIIIII. (2006) Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. Journal of Experimental Medicine 203:1, pages 63-72.
Crossref
Crossref
Ruibao Ren. 2006. Abl Family Kinases in Development and Disease. Abl Family Kinases in Development and Disease
77
92
.
Tomohiko TamuraPratima ThotakuraTetsuya S. TanakaMinoru S. H. KoKeiko Ozato. (2005) Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. Blood 106:6, pages 1938-1947.
Crossref
Crossref
Karine Turcotte, Susan Gauthier, Ashleigh Tuite, Alaka Mullick, Danielle Malo & Philippe Gros. (2005) A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia–like syndrome in BXH-2 mice. Journal of Experimental Medicine 201:6, pages 881-890.
Crossref
Crossref
Ruibao Ren. (2005) Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia. Nature Reviews Cancer 5:3, pages 172-183.
Crossref
Crossref
Chunliu Zhu, Gurveen Saberwal, YuFeng Lu, Leonidas C. Platanias & Elizabeth A. Eklund. (2004) The Interferon Consensus Sequence-binding Protein Activates Transcription of the Gene Encoding Neurofibromin 1. Journal of Biological Chemistry 279:49, pages 50874-50885.
Crossref
Crossref
Junia V Melo & Michael W.N Deininger. (2004) Biology of chronic myelogenous leukemia—signaling pathways of initiation and transformation. Hematology/Oncology Clinics of North America 18:3, pages 545-568.
Crossref
Crossref
Stephane WongOwen N. Witte. (2004) The BCR-ABL Story: Bench to Bedside and Back. Annual Review of Immunology 22:1, pages 247-306.
Crossref
Crossref
Dhananjaya V. Kalvakolanu. (2004) The GRIMs: a new interface between cell death regulation and interferon/retinoid induced growth suppression. Cytokine & Growth Factor Reviews 15:2-3, pages 169-194.
Crossref
Crossref
Grace M Cuenco & Ruibao Ren. (2004) Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice. Oncogene 23:2, pages 569-579.
Crossref
Crossref
Ruibao Ren. (2004) Modeling the dosage effect of oncogenes in leukemogenesis. Current Opinion in Hematology 11:1, pages 25-34.
Crossref
Crossref
Glenn Dranoff. (2004) Cytokines in cancer pathogenesis and cancer therapy. Nature Reviews Cancer 4:1, pages 11-22.
Crossref
Crossref
Ruibao Ren. (2003) Overriding BCR/ABL mitotic signal by ICSBP-induced differentiation. Blood 102:13, pages 4251-4252.
Crossref
Crossref
Tomohiko TamuraHee Jeong KongChainarong TunyaplinHideki TsujimuraKathryn CalameKeiko Ozato. (2003) ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells. Blood 102:13, pages 4547-4554.
Crossref
Crossref
Dhananjaya V. Kalvakolanu. (2003) Alternate interferon signaling pathways. Pharmacology & Therapeutics 100:1, pages 1-29.
Crossref
Crossref
Michal Oskar Nowicki, Peter Pawlowski, Thomas Fischer, Georg Hess, Tomasz Pawlowski & Tomasz Skorski. (2003) Chronic myelogenous leukemia molecular signature. Oncogene 22:25, pages 3952-3963.
Crossref
Crossref
Martin Sattlermc & James D. Griffin. (2003) Molecular mechanisms of transformation by the BCR-ABL oncogene. Seminars in Hematology 40, pages 4-10.
Crossref
Crossref
Martin Sattler, Blanca Scheijen, Ellen Weisberg & James D. Griffin. 2003. New Trends in Cancer for the 21stCentury. New Trends in Cancer for the 21stCentury
121
140
.
Ruibao Ren. (2002) The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model. Oncogene 21:56, pages 8629-8642.
Crossref
Crossref
Maike Schwieger, Jürgen Löhler, Jutta Friel, Marina Scheller, Ivan Horak & Carol Stocking. (2002) AML1-ETO Inhibits Maturation of Multiple Lymphohematopoietic Lineages and Induces Myeloblast Transformation in Synergy with ICSBP Deficiency. Journal of Experimental Medicine 196:9, pages 1227-1240.
Crossref
Crossref
Hideki Tsujimura, Tokiko Nagamura-Inoue, Tomohiko Tamura & Keiko Ozato. (2002) IFN Consensus Sequence Binding Protein/IFN Regulatory Factor-8 Guides Bone Marrow Progenitor Cells Toward the Macrophage Lineage. The Journal of Immunology 169:3, pages 1261-1269.
Crossref
Crossref
Jiang Zhu & Stephen G Emerson. (2002) Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene 21:21, pages 3295-3313.
Crossref
Crossref
Blanca Scheijen & James D Griffin. (2002) Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease. Oncogene 21:21, pages 3314-3333.
Crossref
Crossref
Axel KalliesFrank RosenbauerMarina SchellerKlaus-Peter KnobelochIvan Horak. (2002) Accumulation of c-Cbl and rapid termination of colony-stimulating factor 1 receptor signaling in interferon consensus sequence binding protein–deficient bone marrow–derived macrophages. Blood 99:9, pages 3213-3219.
Crossref
Crossref
Frank Rosenbauer, Axel Kallies, Marina Scheller, Klaus-Peter Knobeloch, Charles O. Rock, Maike Schwieger, Carol Stocking & Ivan Horak. (2002) Disabled-2 is transcriptionally regulated by ICSBP and augments macrophage spreading and adhesion. The EMBO Journal 21:3, pages 211-220.
Crossref
Crossref
Paula M. Pitha & Timothy Alce. 2002. Wiley Encyclopedia of Molecular Medicine. Wiley Encyclopedia of Molecular Medicine.
David J. Barnes & Junia V. Melo. (2002) Cytogenetic and Molecular Genetic Aspects of Chronic Myeloid Leukaemia. Acta Haematologica 108:4, pages 180-202.
Crossref
Crossref
Tomohiko TamuraKeiko Ozato. (2002) Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells. Journal of Interferon & Cytokine Research 22:1, pages 145-152.
Crossref
Crossref
Giovanna Romeo, Gianna Fiorucci, Maria V. Chiantore, Zulema A. Percario, Serena Vannucchi & Elisabetta Affabris. (2002) Review: IRF-1 as a Negative Regulator of Cell Proliferation. Journal of Interferon & Cytokine Research 22:1, pages 39-47.
Crossref
Crossref
Grace M Cuenco & Ruibao Ren. (2001) Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia. Oncogene 20:57, pages 8236-8248.
Crossref
Crossref
Thomas Jahn, Petra Seipel, Sunita Coutinho, Cornelius Miething, Christian Peschel & Justus Duyster. (2001) Grb4/Nckβ Acts as a Nuclear Repressor of v-Abl-induced Transcription from c-jun/c-fosPromoter Elements. Journal of Biological Chemistry 276:46, pages 43419-43427.
Crossref
Crossref
Stephane Wong & Owen N Witte. (2001) Modeling Philadelphia chromosome positive leukemias. Oncogene 20:40, pages 5644-5659.
Crossref
Crossref
Manuel SchmidtAndreas HochhausAndreas NitscheRüdiger HehlmannAndreas Neubauer. (2001) Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α. Blood 97:11, pages 3648-3650.
Crossref
Crossref
Ming DengGeorge Q. Daley. (2001) Expression of interferon consensus sequence binding protein induces potent immunity against BCR/ABL-induced leukemia. Blood 97:11, pages 3491-3497.
Crossref
Crossref
Richard A. Van Etten. (2001) Models of chronic myeloid leukemia. Current Oncology Reports 3:3, pages 228-237.
Crossref
Crossref
Tadatsugu TaniguchiKouetsu OgasawaraAkinori TakaokaNobuyuki Tanaka. (2001) IRF Family of Transcription Factors as Regulators of Host Defense. Annual Review of Immunology 19:1, pages 623-655.
Crossref
Crossref
Martin Sattler & James D. Griffin. (2001) Mechanisms of Transformation by the BCR/ABL Oncogene. International Journal of Hematology 73:3, pages 278-291.
Crossref
Crossref
B. D. Car & V. M. Eng. (2016) Special Considerations in the Evaluation of the Hematology and Hemostasis of Mutant Mice. Veterinary Pathology 38:1, pages 20-30.
Crossref
Crossref
Michael W. N. DeiningerJohn M. GoldmanJunia V. Melo. (2000) The molecular biology of chronic myeloid leukemia. Blood 96:10, pages 3343-3356.
Crossref
Crossref
Michael W. N. DeiningerJohn M. GoldmanJunia V. Melo. (2000) The molecular biology of chronic myeloid leukemia. Blood 96:10, pages 3343-3356.
Crossref
Crossref
Tomohiko Tamura, Tokiko Nagamura-Inoue, Zeevik Shmeltzer, Takeshi Kuwata & Keiko Ozato. (2000) ICSBP Directs Bipotential Myeloid Progenitor Cells to Differentiate into Mature Macrophages. Immunity 13:2, pages 155-165.
Crossref
Crossref
Natesa V. ChidambaramJon E. AngellWang LingEdward R. HofmannDhananjaya V. Kalvakolanu. (2000) Chromosomal Localization of Human GRIM-19, a Novel IFN-β and Retinoic Acid-Activated Regulator of Cell Death. Journal of Interferon & Cytokine Research 20:7, pages 661-665.
Crossref
Crossref
Nobuyuki Tanaka & Tadatsugu Taniguchi. (2000) The interferon regulatory factors and oncogenesis. Seminars in Cancer Biology 10:2, pages 73-81.
Crossref
Crossref